Ars Technica Follow mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say The vaccine reportedly thwarted the cancer's return and spread. https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/ arstechnica.com
